Tag: Alzheimer’s disease
Another Controversial Alzheimer’s Drug
A new treatment for Alzheimer's Disease is promising, but we're not there yet.
Can supplements improve memory and cognition?
Can you reduce the risk of cognitive decline with dietary supplements?
Fraud, Scientific Rigor, and Alzheimer’s Research
A stunning case of possible fraud in Alzheimer's research reinforces the need for scientific rigor at every level.
COVID Associated With Neurodegenerative Disorders
COVID infection has been associated with an increased risk of neurodegenerative and neurovascular disease - another reason to keep our eye on this serious illness.
Medicare and Medicaid place restrictions on new Alzheimer’s drug, Aduhelm (aducanumab)
An important decision has been made about a controversial new drug to treat Alzheimer's disease.
Poor Science Reporting and Premature Enthusiasm
Press releases often outpace the data. Here are some examples of over-enthusiastic reporting on extremely preliminary research.
FDA’s Decision to Approve Aduhelm (aducanumab) for Alzheimer’s
Criticism of the FDA's decision to approve aducanumab for Alzheimer's disease.
No evidence, no problem: A closer look at the aducanumab approval
Why did the FDA approve aducanumab, a drug that hasn't been shown to work?
Can mRNA-based COVID-19 vaccines cause prion disease or Alzheimer’s?
Antivax immunologist J. Bart Classen published a paper claiming that mRNA-based COVID-19 vaccines can cause prion disease leading to neurodegenerative diseases like Alzheimer's dementia. What are prions, and can these vaccines cause prion disease? (Spoiler alert: The answer to the second question is almost certainly no. It's speculation based on highly implausible biology.)
Would you pay $1 million to enroll in a phase 1 clinical trial of an “anti-aging” gene therapy?
Libella Gene Therapeutics, LLC made the news last week for announcing a "pay-to-play" trial of its telomerase-based anti-aging gene therapy. What was shocking about the announcement was not that it was a "pay-to-play" trial, given that such trials have become all too common, but rather the price of enrollment: $1 million. Worse, the trial is being conducted in Colombia; the therapy doesn't...